The Paul F. Harron, Jr. Family Professorship

Paul F. Harron

Created in 2007 by the Harron family, the Professorship honors Paul F. Harron, Jr.’s desire to support Penn Medicine’s lung center and his esteem for his physician John Hansen-Flaschen, MD.

In 2014, the family again honored Mr. Harron’s wishes by establishing the Paul F. Harron, Jr. Lung Center. This multidisciplinary center provides the most advanced diagnosis and treatment of lung disorders with a focus on coordinated, patient-centered care. The Center is based in the Pulmonary, Allergy and Critical Care Division of the Department of Medicine, and the chairholder serves as Director of the Center.

Paul F. Harron, Jr. (1942–2005) was President of his family’s media company Harron Communications Corp. He was actively involved in the cable television industry throughout his life, including as a founding member of C-SPAN. Mr. Harron was posthumously inducted into the Broadcast Pioneers Hall of Fame in 2010.

In his memory, the Harron family has created a multidisciplinary center for the diagnosis and treatment of lung disorders and two professorships that bear his name.

 

Jason D. ChristieCurrent Chairholder
Jason D. Christie, MD, MSCE

Jason D. Christie, MD, MSCE is Chief of the Pulmonary, Allergy, and Critical Care Division, Professor of Medicine in the Department of Medicine, and Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the Perelman School of Medicine. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury in transplant and non-transplant patients. Through the leadership of the Center for Translational Lung Biology, Dr. Christie brings together clinicians, bench scientists, epidemiologists, and statisticians to build multidisciplinary research teams. His research integrates new knowledge generated from bench studies with epidemiology approaches in large, well-phenotyped human populations to generate new definitions of human syndromes, improved diagnostics and prognostics, and targeted therapy approaches in advanced lung diseases and critical illness.
 

Previous Chairholders

  • John H. Hansen-Flaschen, MD